Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Accounts Payables (2021 - 2025)

LifeStance Health (LFST) has disclosed Accounts Payables for 5 consecutive years, with $6.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Accounts Payables fell 15.47% to $6.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $6.1 million, a 15.47% decrease, with the full-year FY2025 number at $6.1 million, down 15.47% from a year prior.
  • Accounts Payables was $6.1 million for Q4 2025 at LifeStance Health, down from $12.2 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $15.1 million in Q1 2022 to a low of $3.1 million in Q3 2021.
  • A 5-year average of $9.4 million and a median of $8.0 million in 2023 define the central range for Accounts Payables.
  • Peak YoY movement for Accounts Payables: skyrocketed 158.52% in 2022, then plummeted 49.07% in 2023.
  • LifeStance Health's Accounts Payables stood at $14.2 million in 2021, then fell by 13.19% to $12.3 million in 2022, then crashed by 42.6% to $7.1 million in 2023, then increased by 2.71% to $7.2 million in 2024, then decreased by 15.47% to $6.1 million in 2025.
  • Per Business Quant, the three most recent readings for LFST's Accounts Payables are $6.1 million (Q4 2025), $12.2 million (Q3 2025), and $7.8 million (Q2 2025).